Evidence map›Paper›PMID 31614123›Full record

ArticleGastroenterology2020

Does Colon Polyp Surveillance Improve Patient Outcomes?

David Lieberman, Samir Gupta

Abstract read
In one paragraph

Article in Gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cause, Epidemiology, and Histology of Polyps and Pathways to Colorectal Cancer.Gastrointestinal endoscopy clinics of North America · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David LiebermanDivision of Gastroenterology and Hepatology, Oregon Health and Science University, Portland, Oregon. Electronic address: lieberma@ohsu.edu.
Samir GuptaGI Section, San Diego Veterans Affairs Healthcare System, San Diego, California; Division of Gastroenterology, Department of Internal Medicine, Moores Cancer Center, University of California San Diego, San Diego, California.

Funding

Post-polypectomy Surveillance for Reducing Colon Cancer Incidence and MortalityR37CA222866 · NCI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GUPTA, SAMIR · 2018 to 2023
$3.3M
CRC-HUB-SPOKE: A ColoRectal Cancer screening Hub for Southern California community health centers.UG3CA233314 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CASTANEDA, SHEILA FAYE, GUPTA, SAMIR · 2019 to 2019
$604k
Optimizing Colorectal Cancer and Polyp Surveillance after Colorectal PolypectomyI01HX001574 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI GUPTA, SAMIR · 2015 to 2019
–
HSRD VA I01 HX001574NCI NIH HHS R37 CA222866NCI NIH HHS UG3 CA233314
6 · The paper itself

Abstract

Colon polyp surveillance now accounts for 25% of all colonoscopies performed. The evidence that colonoscopy surveillance reduces colorectal cancer (CRC) incidence or mortality is weak. The biology of the baseline lesions and quality of the baseline exam are two primary factors contributing to post-colonoscopy CRC. Prior recommendations for surveillance were based largely on the likelihood that patients with adenomas would develop advanced adenomas, a surrogate for CRC. There is now evidence that baseline colonoscopy findings are strongly associated with the risk of incidence or death from CRC. This evidence provides a basis for updated evidence-based recommendations for surveillance. In addition, there is also growing evidence that the quality of the baseline exam is an important predictor of the likelihood of developing post-colonoscopy CRC.

Indexed as

ColonoscopyAdenomatous PolypsColonic PolypsColorectal NeoplasmsDisease ProgressionEarly Detection of CancerHumansIncidencePredictive Value of TestsPrognosisRisk AssessmentRisk FactorsTime FactorsColonoscopyColon PolypColon Polyp SurveillanceColorectal Cancer

Identifiers

PMID31614123
PMCPMC7340328

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.